Cooperative Agreement P50CA180906

This $2,490,060 Cooperative Agreement award from the National Institutes of Health (NIH) Office of the Director under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077) will assess the effects of FDA tobacco product risk continuum messaging on adult users of combustible tobacco products and youth/young adults. The project aims to: 1) generate rankings of messages and identify effective message features based on perceived effectiveness and...

The University of Southern California received a $611,084 Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077). The grant will fund a research project to assess the effects of nicotine concentration and pH levels in nicotine pouches on sensory attributes, product appeal, and abuse liability among young adult dual users of nicotine pouches and e-cigarettes....

This federal Project Grant award of $188,913, provided by the National Institutes of Health (NIH) Office of the Director under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077), supports research aimed at understanding perceptions of the continuum of risk associated with nicotine-containing products among socioeconomically disadvantaged adult smokers. The research, conducted by Virginia Commonwealth University, has three key objectives: 1)...

This Project Grant award from the National Institutes of Health (NIH) Office of the Director, under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077), provides $622,957 to Duke University over a 4-year period from August 2024 to July 2028. The funding supports research to analyze the chemical composition and behavioral effects of novel tobacco products, including oral nicotine pouches and "non-menthol" cigarettes recently introduced to...

This Project Grant award of $549,555.45, under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077) administered by the National Institutes of Health (NIH) Office of the Director, supports research to investigate the exposure and respiratory health effects from the use of electronic cigarettes (e-cigarettes) among young adults. The primary objectives are to: 1) evaluate the relationship between e-cigarette use and exposure to chemical constituents of...

This federal Project Grant award, funded by the National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310), will support a research study on the "Implementation, Reach, and Impact of Court-Ordered Tobacco Corrective Statement Postings at the Point-of-Sale." The $675,599 grant, awarded on September 1, 2024, with a completion date of August 31, 2025, aims to characterize the implementation and reach of court-ordered tobacco corrective statement signage...

This Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077) will investigate the cardiovascular effects of dual use of cigarettes and e-cigarettes. The $1,615,000 award to the Regents of the University of California, San Francisco will fund a 5-year research project with the following objectives: Understand the cardiovascular health effects of dual use of a range...

This Project Grant award from the National Cancer Institute (NCI), under the Cancer Cause and Prevention Research program (CFDA 93.393), will provide $885,824 to Health Research, Inc. over a period of 2 years beginning August 1, 2024 to explore consumer responses to newly authorized modified risk claims for smokeless tobacco products. The research aims to: 1) assess consumers' exposure and reactions to these modified risk claims, and 2) determine whether the claims influence consumer demand...

This Project Grant award from the National Cancer Institute (NCI), under the federal Cancer Cause and Prevention Research program (CFDA 93.393), will provide $310,319 to the University of Louisville to conduct formative research on a motivation-based typology of adolescent e-cigarette users. The goal is to inform the development of tailored cognitive behavioral cessation interventions that are developmentally appropriate and acceptable to this population. The project will recruit a sample of...

This Project Grant award from the National Cancer Institute (NCI), under the federal grant program "Cancer Cause and Prevention Research" (CFDA 93.393), will fund research to identify effective communication strategies on social media platforms to promote vaping cessation among youth and young adults. The $565,181 award, spanning from September 1, 2024 to August 31, 2029, will enable the University of Rochester to characterize key features of e-cigarette-related posts on Twitter,...